NCT05366140 Thoracic-Lumbar Arthrodesis- Implanet Jazz
| NCT ID | NCT05366140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Francis Farhadi |
| Condition | Spondylolisthesis |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-02-03 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-02-03 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Establish a data repository of patients who have undergone single, two-, or three-level lumbar instrumented arthrodesis procedures supplemented by the Implanet Jazz System.
Eligibility Criteria
Inclusion Criteria: * Male and female patients, 18 years of age and older * Qualified candidate for hybrid thoracolumbar fixation with the Implanet Jazz System TM during arthrodesis surgery. Exclusion Criteria: * Individuals who have not yet reached the age of 18.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05366140 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Spondylolisthesis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05366140 currently recruiting?
Yes, NCT05366140 is actively recruiting participants. Contact the research team at Francis.Farhadi@uky.edu for enrollment information.
Where is the NCT05366140 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT05366140 clinical trial?
NCT05366140 is sponsored by Francis Farhadi. The trial plans to enroll 300 participants.